GARDP Webinar: How can non-profit drug developers counter AMR?

Antibiotics underpin modern medicine and are critical for pandemic preparedness. The aim of the webinar is to highlight the value of the nonprofit R&D business model in tackling antimicrobial resistance (AMR). It will look at the importance of public-private partnerships, such as GARDP, in accelerating the development and access to new and improved treatments for drug-resistant infections.  The webinar will feature experts who have been deeply involved in the non-profit public health sector and are committed to introducing new health treatments for priority public health needs.

We will be joined by:

Laura Piddock, Scientific Director, GARDP

Pietro Turilli, Senior Vice President, External Affairs, TB Alliance

Monique Wasunna, Director, DNDi Eastern Africa

Moderated by: Claire Doole

More information is available on our website: https://gardp.org/events/webinar-how-can-a-nonprofit-drug-development-model-counter-amr/

The registration link is available here: Register here